Human cancer, carcinogenic exposures and mutation spectra

Mutation Research - Reviews in Mutation Research

Volumn 436, Issue 2, 1999, Pages 185-194

  Vineis, Paolo ^a   Malats, Nuria ^b   Porta, Miquel ^b   Real, Francisco X ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Carcinogenic exposure; Molecular epidemiology; Mutation spectrum

Indexed keywords

CARCINOGEN; MUTAGENIC AGENT; RADON;

BIOLOGICAL MODEL; EPIDEMIOLOGY; GENETICS; HUMAN; METHODOLOGY; MUTATION; NEOPLASM; ONCOGENE; RADIATION EXPOSURE; REVIEW; TUMOR SUPPRESSOR GENE;

BIAS (EPIDEMIOLOGY); CARCINOGENS; GENES, P53; GENES, TUMOR SUPPRESSOR; HUMANS; MODELS, GENETIC; MUTAGENS; MUTATION; NEOPLASMS; ONCOGENES; RADON; RESEARCH DESIGN;

EID: 33645709633     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. E. Dogliotti, P. Hainaut, T. Hernandez, M.R. D'Errico, D. DeMarini, Mutation spectra resulting from carcinogenic exposure: from model systems to cancer-related genes, Recent Results in Cancer Research, Springer-Verlag, 1998 (in press).
2. C. Coulondre, J.A. Miller, Genetic studies of the lac repressor: IV. Mutagenic specificity in the lad gene of Escherichia cou, J. Molec. Biol. 117 (1977) 577-606.
3. J.A. Miller, C. Coulondre, M. Hofer, U. Schmeissner, H. Sommer, A. Schmilz, P. Lu, Genetic studies of the lac repressor: IX. Generation of altered proteins by the suppression of nonsense mutations, J. Molec. Biol. 131 (1979) 191-222.
4. M.F. Denissenko, A. Pao, M. Tang, O.P. Pfeifer, Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53, Science 274 (1996) 430-432.
5. M.F. Denissenko, A. Pao, O.P. Pfeifer, M. Tang, Slow repair of bulky DNA adducts along the nontranscribed strand of the human p53 gene may explain the strand bias of transversion mutations in cancers, Oncogene 16 (1998) 1241-1247.
6. M.F. Denissenko, J.X. Chen, M.S. Tang, O.P. Pfeifer, Cytosine methylation determines hot spots of DNA damage in the human P53 gene, Proc. Natl. Acad. Sei. USA 94 (1997) 3893-3898.
7. M. Nagao, T. Ushijima, K. Wakabayashi, Dietary carcinogens and mammary carcinogenesis, Cancer 74 (1994) 1063-1069.
8. F.F. Li, R.H. Heflich, T.J. Bucci, M.G. Manjanatha, B.S. Blaydes, K.B. Delclos, Relationships of DNA adduct formation, K-ras activation, mutations and tumorigenic activities of 6-nitrochrysene and its metabolites in the lungs of CD-1 mice, Carcinogenesis 15 (1994) 1377-1385.
9. D. DeMarini, Mutation spectra of complex mixtures, Mutation Res., 1998, 400 (in press).
10. B. Bressac, M. Kew, J. Wands, M. Ozturk, Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa, Nature 350 (1991) 429-431.
11. I.C. Hsu, R.A. Metcalf, T. Sun, J.A. Welsh, N.J. Wang, C.C. Harris, Mutational hotspots in the p53 gene in human hepatocellular carcinomas, Nature 350 (1991) 427-428.
12. J.E. Hulla, Z.Y. Chen, D.L. Eaton, Aflatoxin Bl-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene, Cancer Res. 53 (1993) 9-11.
13. Y. Tokusashi, I. Fukuda, K. Ogawa, Absence of p53 mutations and various frequencies of Ki-ras exon 1 mutations in rat hepatic tumors induced by different carcinogens, Molecular Carcinogenesis 10 (1994) 45-51.
14. D.E. Brash, J.A. Rudolph, J.A. Simon, A. Lin, G.J. McKenna, H.P. Baden, A.J. Halperin, J. Ponten, A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma, Proc. Natl. Acad. Sei. USA 88 (1991) 10124-10128.
15. R.S. Cha, W.O. Thilly, H. Zarbl, Af-nitroso-;V-methylurea-induced rat mammary tumors arise from cells with preexisting oncogenic Hrasl gene mutations, Proc. Natl. Acad. Sei. USA 91 (1994) 3749-3753.
16. B. Vogelstein, E.R. Fearon, S.H. Hamilton, Genetic alterations during colorectal tumor development, N. Engl. J. Med. 319 (1988) 525-532.
17. C.C. Harris, Chemical and physical Carcinogenesis: advances and perspectives for the 1990's, Cancer Res. 51 (1991) 5023s-5044s.
18. P. Vineis, M. Porta, Causal thinking, biomarkers and mechanisms of Carcinogenesis, J. Clin. Epidemiol. 9 (1996) 951-956.
19. J. Leon, I. Guerrero, A. Pellicer, Differential expression of the ras gene family in mice, Mol. Cell. Biol. 7 (1987) 1535-1540.
20. K.W. Kinzler, B. Vogelstein, Cancer susceptibility genes: gatekeepers and caretakers, Nature 386 (1997) 761-763.
21. G.P. Holmquist, S. Gao, Somatic mutation theory, DNA repair rates and the molecular epidemiology of p53 mutations, Mutation Res. 386 (1997) 69-101.
22. R. Kumar, S. Sukumar, M. Barbacid, Activation of ras oncogenes preceding the onset of neoplasia, Science 248 (1990) 1101-1104.
23. K.H. Vahakangas, J.M. Samet, R.A. Metcalf, J.A. Welsh, W.P. Bennett, O.P. Lane, C.C. Harris, Mutations of p53 and ras genes in radon-associates lung cancer from uranium miners, Lancet 339 (1992) 576-580.
24. J.A. Taylor, M.A. Watson, T.R. Devereux, R.Y. Michels, G. Saccomanno, M. Anderson, P53 mutation hotspot in radonassociated lung cancer, Lancet 343 (1994) 86-87.
25. S. Venitt, P.J. Biggs, Radon, mycotoxins, p53, and uranium mining, Lancet 343 (1994) 795.
26. T.K. Hei, J. Bedford, C.A. Waldren, p53 Mutation hotspot in radon-associated lung cancer, Lancet 343 (1994) 1158.
27. J.A. Taylor, M. Anderson, p53 Mutation hotspot in radonassociated lung cancer, Lancet 343 (1994) 1158-1159.
28. H. Bartsch, M. Hollstein, R. Mustonen, J. Schmidt, A. Spiethoff, H. Wesch, T. Wiethege, K.-M. Muller, Screening for putative radon-specific p53 mutation hotspot in German uranium miners, Lancet 346 (1995) 121.
29. J.W. McDonald, J.A. Taylor, M.A. Watson, G. Saccomanno, T.R. Devereux, P53 and K-ras in radon-associated lung cancer, Cancer Epidemiol. Biomarkers and Prev. 4 (1995) 791-793.
30. S.P. Hussain, C.H. Kennedy, P. Amstad, H. Lui, J.F. Lechner, C.C. Harris, Radon and lung carcinogenesis: mutability of p53 codons 249 and 250 to 238Pu alpha-particles in human bronchial epithelial cells, Carcinogenesis 18 (1997) 121-125.
31. C. Caldas, S.E. Kern, K-ras mutations and pancreatic cancer, Int. J. Panceratol. 18 (1995) 1-6.
32. G.T. Noordhoek, J.D.A. van Embden, A.H.J. Kolk, Questionable reliability of the polymerase chain reaction in the detection of Mycobacterium tuberculosis, N. Engl. J. Med. 329 (1993)2036.
33. H.L. Zaaijer, H.T.M. Cuypers, H.W. Reesink, I.N. Winkel, G. Gerken, P.N. Lelie, Reliability of polymerase chain reaction for detection of hepatitis C virus, Lancet 341 (1993) 722-724.
34. O. Mor, Z. Grossman, O. Jakobovitz, F. Brok-Simoni, G. Rechavi, Artifactual p53 mutations: possible effect of gene secondary structure on PCR and direct sequence analysis, Lancet 340(1992) 1236.
35. T.R. Yaeger, S. de Vries, D.E. Jarrard, C. Kao, S.Y. Nakada, T.D. Moon, R. Bruskewitz, W.M. Stadier, L.F. Meisner, K.W. Gilchrist, M.A. Newton, P.M. Waldman, C.A. Reznikoff, Overcoming cellular senescence in human cancer pathogenesis, Genes Dev. 12 (1998) 163-174.
36. A. Achille, M.O. Biasi, G. Zamboni, G. Bogina, A.R. Magalini, P. Pederzoli, M. Perucho, A. Scarpa, Chromosome 7q allelic losses in pancreatic carcinoma, Cancer Res. 56 (1996) 3803-3813.
37. S.P. Dowell, P.A. Hall, The clinical relevance of the p53 tumour suppressor gene, Cytopathology 5 (1994) 133-145.
38. C.B. Begg, J.A. Berlin, Publication bias: a problem in interpreting medical data, J.R. Statist. Soc. 151 (1988) 419-463, Part 3.
39. P. Hainaut, T.M. Hernandez, A. Robison, P. Rodriguez-Tome, T. Flores, M. Hollstein, C.C. Harris, R. Montesano, IARC database of p53 gene mutations in human tumors and cell lines: updated compilation, revised formats and new visualization tools, Nucl. Acid Res. 26 (1998) 205-213.
40. P. Lamb, L. Crawford, Characterization of the human p53 gene, Mol. Cell Biol. 6 (1986) 1379-1385.
41. W.T. Adams, T.R. Skopek, Statistical test for the comparison of samples from mutational spectra, J. Molec. Biol. 194 (1987) 391-396.
42. N.F. Cariello, W.W. Piegorsch, W.T. Adams, T.R. Skopek, Computer program for the analysis of mutational spectra: Application to p53 mutations, Carcinogenesis, 1994, 2281-2285.
43. M.T. Barrett, C.A. Sanchez, P.C. Galipeau, K. Neshat, M. Emond, B.J. Reid, Allelic loss of 9p21 and mutation of the CDKN2/p16 gene develop as early lesions during neoplastic progression in Barren's esophagus, Oncogene 13 (1996) 1867-1873.